BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22257580)

  • 21. Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison.
    Zhao X; Ning R; Hui A; Boulton DW; Tang W
    Clin Ther; 2023 Aug; 45(8):762-769. PubMed ID: 37442656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence and pharmacokinetic comparison of 3 metformin extended/sustained release tablets in healthy Indian male volunteers.
    Batolar LS; Iqbal M; Monif T; Khuroo A; Sharma PL
    Arzneimittelforschung; 2012 Jan; 62(1):22-6. PubMed ID: 22331759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects.
    Goak IS; Lee JA; Jeong MH; Moon SJ; Kim MG
    Drug Des Devel Ther; 2022; 16():4439-4448. PubMed ID: 36597442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy Subjects.
    Tang W; Engman H; Zhu Y; Dayton B; Boulton DW
    Clin Ther; 2019 Aug; 41(8):1545-1563. PubMed ID: 31266654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects.
    Dawra VK; Cutler DL; Zhou S; Krishna R; Shi H; Liang Y; Alvey C; Hickman A; Saur D; Terra SG; Sahasrabudhe V
    Clin Pharmacol Drug Dev; 2019 Apr; 8(3):314-325. PubMed ID: 29786959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a Lobeglitazone/Metformin Fixed-Dose Combination Tablet (CKD-395 0.5/1000 mg) Versus Concomitant Administration of Single Agents and the Effect of Food on the Metabolism of CKD-395 in Healthy Male Subjects.
    Kim SY; Jeon JY; Park SJ; Kim MG
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):576-584. PubMed ID: 30329224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy Volunteers.
    Jung SH; Chae JW; Song BJ; Kwona KI
    Iran J Pharm Res; 2014; 13(2):365-71. PubMed ID: 25237332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison study of two glimepiride formulations bioavailability in healthy volunteers of both sexes after a single dose administration].
    Borges NC; Taveira Ydel A; Mazucheli JA; Haddad AL; Astigarraga RE; Moreno RA
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):950-5. PubMed ID: 17934662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of a fixed-dose combination of mitiglinide and metformin versus concurrent administration of individual formulations in healthy subjects: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover study.
    Jung JA; Kim JR; Kim SR; Kim TE; Lee SY; Ko JW; Huh W
    Clin Drug Investig; 2012 Dec; 32(12):799-804. PubMed ID: 23100167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence assessment of the two brands of glimepiride tablets.
    Jovanović D; Stojsić D; Zlatković M; Jović-Stosić J; Jovanović M
    Vojnosanit Pregl; 2006 Dec; 63(12):1015-20. PubMed ID: 17252706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers.
    Choi HY; Kim YH; Kim MJ; Lee SH; Bang K; Han S; Lim HS; Bae KS
    Drugs R D; 2014 Sep; 14(3):165-76. PubMed ID: 24962635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers.
    Li J; Jin Y; Wang TY; Lü XW; Li YH
    Eur J Drug Metab Pharmacokinet; 2007; 32(1):21-8. PubMed ID: 17479540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects.
    Khomitskaya Y; Tikhonova N; Gudkov K; Erofeeva S; Holmes V; Dayton B; Davies N; Boulton DW; Tang W
    Clin Ther; 2018 Apr; 40(4):550-561.e3. PubMed ID: 29548719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability.
    de Bruin TW; Reele S; Hamer-Maansson JE; Parikh S; Tang W
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):118-30. PubMed ID: 27138025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic study of metformin to compare voglibose/metformin fixed-dose combination with coadministered voglibose and metformin.
    Choi HK; Oh M; Kim EJ; Song GS; Ghim JL; Shon JH; Kim HS; Shin JG
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):147-53. PubMed ID: 25546164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic modeling of glimepiride plasma concentration in healthy subjects.
    Antonesi IM; Potur R; Potur DM; Ghiciuc CM; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):949-53. PubMed ID: 22046814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence and pharmacokinetic evaluation of two formulations of glimepiride 2 mg: a single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Zhang MQ; Zhu JM; Jia JY; Liu YM; Liu GY; Li S; Weng LP; Yu C
    Clin Ther; 2010 May; 32(5):986-95. PubMed ID: 20685507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.